48,860
edits
Difference between revisions of "Prostate cancer"
Jump to navigation
Jump to search
→Active surveillance
(w) |
|||
| Line 37: | Line 37: | ||
=====Active surveillance===== | =====Active surveillance===== | ||
The ''Klotz'' criteria for active surveillance:<ref name=pmid22314081/><ref>{{Cite journal | last1 = Klotz | first1 = L. | title = Active surveillance for prostate cancer: for whom? | journal = J Clin Oncol | volume = 23 | issue = 32 | pages = 8165-9 | month = Nov | year = 2005 | doi = 10.1200/JCO.2005.03.3134 | PMID = 16278468 }}</ref> | The ''Klotz'' criteria for active surveillance - pathologic factors only:<ref name=pmid22314081/><ref>{{Cite journal | last1 = Klotz | first1 = L. | title = Active surveillance for prostate cancer: for whom? | journal = J Clin Oncol | volume = 23 | issue = 32 | pages = 8165-9 | month = Nov | year = 2005 | doi = 10.1200/JCO.2005.03.3134 | PMID = 16278468 }}</ref> | ||
*Gleason score 6 or less. | *Gleason score 6 or less. | ||
*All biopsies cores < 50% involvement. | *All biopsies cores < 50% involvement. | ||